| scholarly article | Q13442814 |
| P50 | author | Chen Chien-jen | Q9182314 |
| Chen-Yang Shen | Q73926370 | ||
| P2093 | author name string | Kuan-Yu Chen | |
| Pan-Chyr Yang | |||
| Chao A Hsiung | |||
| Chih-Yi Chen | |||
| Wu-Chou Su | |||
| Gee-Chen Chang | |||
| Yuh-Min Chen | |||
| Ying-Huang Tsai | |||
| Tsung-Ying Yang | |||
| Chung-Ping Hsu | |||
| Cheng-Yen Chuang | |||
| Jiun-Yi Hsia | |||
| Kun-Chieh Chen | |||
| Kuo-Hsuan Hsu | |||
| Ming-Shyan Huang | |||
| Yao-Jen Li | |||
| Chi-Ren Tsai | |||
| Kuo-Meng Liao | |||
| Shi-Yi Yang | |||
| P2860 | cites work | ERCC4Associated with Breast Cancer Risk: A Two-Stage Case-Control Study Using High-throughput Genotyping | Q57305922 |
| EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Q27824812 | ||
| The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies | Q27851393 | ||
| A common polymorphism acts as an intragenic modifier of mutant p53 behaviour | Q28118809 | ||
| Genome maintenance mechanisms for preventing cancer | Q28131737 | ||
| NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms | Q28142533 | ||
| DNA mismatch repair and mutation avoidance pathways | Q28211143 | ||
| Binding of mismatched microsatellite DNA sequences by the human MSH2 protein | Q28241673 | ||
| The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer | Q28256988 | ||
| Genomic instability--an evolving hallmark of cancer | Q28274009 | ||
| Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 | ||
| The cancer genome | Q29547643 | ||
| Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers | Q29615475 | ||
| A permutation test for inference in logistic regression with small- and moderate-sized data sets | Q30974339 | ||
| Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. | Q34536780 | ||
| Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors | Q34666826 | ||
| Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions | Q34762342 | ||
| Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung | Q34975657 | ||
| Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer | Q35190796 | ||
| Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms | Q36082004 | ||
| Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants | Q36152083 | ||
| Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). | Q36419978 | ||
| Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). | Q37481884 | ||
| Using germline genotype in cancer pharmacogenetic studies | Q37570332 | ||
| Genetically informed lung cancer medicine | Q37815136 | ||
| Frequency of and variables associated with the EGFR mutation and its subtypes | Q38420729 | ||
| Molecular mechanisms of estrogen carcinogenesis | Q41048133 | ||
| DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma | Q42755164 | ||
| Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan | Q43293823 | ||
| Gender difference in DNA adduct levels among nonsmoking lung cancer patients | Q43652344 | ||
| A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis | Q44711352 | ||
| EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients. | Q51507308 | ||
| Correlation between HLA alleles and EGFR mutation in Japanese patients with adenocarcinoma of the lung. | Q51559932 | ||
| Soy consumption reduces the risk of non-small-cell lung cancers with epidermal growth factor receptor mutations among Japanese. | Q53481776 | ||
| Potentially functional polymorphisms of EXO1 and risk of lung cancer in a Chinese population: A case-control analysis. | Q53511012 | ||
| Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. | Q54627139 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 449-458 | |
| P577 | publication date | 2012-06-28 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients. | |
| P478 | volume | 132 |
| Q91689769 | Association of EGFR mutations and HMGB1 genetic polymorphisms in lung adenocarcinoma patients |
| Q36046488 | Genetic risk of lung cancer associated with a single nucleotide polymorphism from EXO1: a meta analysis. |
| Q34348237 | Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations |
| Q47131812 | NQO1 C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis |
| Q33584181 | The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis |
Search more.